Nathalie Van den Berghe

4PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityGene and molecular therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations.

Nathalie Van den Berghe, Bram Verstockt, Ann Gils

|Nov 03, 2019
Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic Arthritis.

Jessica Vandenhaute, Anneleen Avau, Jessica Filtjens

|Aug 18, 2019
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?

Nathalie Van den Berghe, Ann Gils, Debby Thomas

|Apr 21, 2019
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis.

N Van den Berghe, E De Keyser, R Soenen

Pageof 1